-
CBMG Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Cellular Biomedicine (CBMG)
Company Profile
Quarter (USD) | Sep 20 | Jun 20 | Mar 20 | Sep 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 19 | Dec 18 | Dec 17 | Dec 16 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 26.03 mm | 26.03 mm | 26.03 mm | 26.03 mm | 26.03 mm | 26.03 mm |
Cash burn (monthly) | (no burn) | 2.56 mm | 5.90 mm | 4.94 mm | 4.45 mm | 3.56 mm |
Cash used (since last report) | n/a | 133.04 mm | 306.76 mm | 256.93 mm | 231.58 mm | 185.29 mm |
Cash remaining | n/a | -107.02 mm | -280.73 mm | -230.90 mm | -205.56 mm | -159.26 mm |
Runway (months of cash) | n/a | -41.9 | -47.6 | -46.8 | -46.2 | -44.7 |
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 31.39 mm |
Total shares | 2.07 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Sailing Capital Overseas Investments Fund | 1.71 mm | $25.95 mm |
TF Venture Capital Management | 358.97 k | $5.44 mm |
Liu Tony | 12.00 | $0.00 |